2-(5-(2-hydroxyphenyl)-1-(3-methoxyphenyl)-1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)phenol

ID: ALA5182915

PubChem CID: 168279488

Max Phase: Preclinical

Molecular Formula: C22H16F3N3O3

Molecular Weight: 427.38

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cccc(-n2nc(-c3ccc(C(F)(F)F)cc3O)nc2-c2ccccc2O)c1

Standard InChI:  InChI=1S/C22H16F3N3O3/c1-31-15-6-4-5-14(12-15)28-21(17-7-2-3-8-18(17)29)26-20(27-28)16-10-9-13(11-19(16)30)22(23,24)25/h2-12,29-30H,1H3

Standard InChI Key:  VAXCEESSFVGPDU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0844   -1.2394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5829   -0.7546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.0301    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4969    0.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7519   -0.7546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9095    0.7447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4971    1.4594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9091    2.1715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7345    2.1715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1464    1.4612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7382    0.7447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1471    2.8861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9723    2.8861    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1471    3.7128    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4325    3.2987    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3279    1.4594    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800   -0.9681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5938   -1.7651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3886   -1.9773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9723   -1.3937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7613   -0.6002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9659   -0.3822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7524    0.4148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0844   -2.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7990   -2.4774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7982   -3.3001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -3.7128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6284   -3.3037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6332   -2.4789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5128   -3.7127    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2274   -3.3001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  4  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
  6 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
  7 16  1  0
 17  2  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 22 23  1  0
 24  1  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
 24 29  1  0
 26 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5182915

    ---

Associated Targets(Human)

HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.38Molecular Weight (Monoisotopic): 427.1144AlogP: 5.04#Rotatable Bonds: 4
Polar Surface Area: 80.40Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.61CX Basic pKa: CX LogP: 5.85CX LogD: 5.64
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.48Np Likeness Score: -1.13

References

1. Lao Y, Wang Y, Chen J, Huang P, Su R, Shi J, Jiang C, Zhang J..  (2022)  Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.,  236  [PMID:35390713] [10.1016/j.ejmech.2022.114315]

Source